Znanstveni rad - Izvorni znanstveni rad
Relationship Between Vascular Endothelial Growth Factor and Nuclear Factor-κB in Renal Cell Tumors
Croatian medical journal, 49 (2008), 5; 608-617. urn:nbn:hr:184:348620


Citirajte ovaj rad

Đorđević, G., Matušan Ilijaš, K., Sinožić, E., Damante, G., Fabbro, D., Grahovac, B. ... Jonjić, N. (2008). Relationship Between Vascular Endothelial Growth Factor and Nuclear Factor-κB in Renal Cell Tumors. Croatian medical journal, 49. (5), 608-617. Preuzeto s https://urn.nsk.hr/urn:nbn:hr:184:348620

Đorđević, Gordana, et al. "Relationship Between Vascular Endothelial Growth Factor and Nuclear Factor-κB in Renal Cell Tumors." Croatian medical journal, vol. 49, br. 5, 2008, str. 608-617. https://urn.nsk.hr/urn:nbn:hr:184:348620

Đorđević, Gordana, Koviljka Matušan Ilijaš, Emina Sinožić, Giuseppe Damante, Dora Fabbro, Blaženka Grahovac, Ksenija Lučin i Nives Jonjić. "Relationship Between Vascular Endothelial Growth Factor and Nuclear Factor-κB in Renal Cell Tumors." Croatian medical journal 49, br. 5 (2008): 608-617. https://urn.nsk.hr/urn:nbn:hr:184:348620

Đorđević, G., et al. (2008) 'Relationship Between Vascular Endothelial Growth Factor and Nuclear Factor-κB in Renal Cell Tumors', Croatian medical journal, 49(5), str. 608-617. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:184:348620 (Datum pristupa: 22.09.2021.)

Đorđević G, Matušan Ilijaš K, Sinožić E, Damante G, Fabbro D, Grahovac B, i sur.. Relationship Between Vascular Endothelial Growth Factor and Nuclear Factor-κB in Renal Cell Tumors. Croatian medical journal [Internet]. 15.10.2008. [pristupljeno 22.09.2021.];49(5):608-617. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:348620

G. Đorđević, et al., "Relationship Between Vascular Endothelial Growth Factor and Nuclear Factor-κB in Renal Cell Tumors", Croatian medical journal, vol. 49, br. 5, str. 608-617, Listopad 2008. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:348620. [Citirano: 22.09.2021.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.